OTCMKTS:ABMT

Advanced BioMedical Technologies (ABMT) Stock Price, News & Analysis

$0.0006
0.00 (0.00%)
(As of 04/24/2024 ET)
Today's Range
$0.0006
$0.0006
50-Day Range
$0.00
$0.04
52-Week Range
$0.00
$0.09
Volume
N/A
Average Volume
103 shs
Market Capitalization
$42,540.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ABMT stock logo

About Advanced BioMedical Technologies Stock (OTCMKTS:ABMT)

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

ABMT Stock Price History

ABMT Stock News Headlines

Biden replacement revealed?
A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.
Biden replacement revealed?
A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.
Abbott (ABT) Gains From Global Expansion Amid Macro Woes
Advanced BioMedical Technologies Inc ABMT
Advanced BioMedical Technologies Inc.
BTIG Reaffirms Their Buy Rating on Abbott Labs (ABT)
See More Headlines
Receive ABMT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced BioMedical Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/25/2024
Fiscal Year End
10/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:ABMT
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$270,000.00
Book Value
($0.11) per share

Miscellaneous

Free Float
46,719,000
Market Cap
$42,540.00
Optionable
Not Optionable
Beta
-0.14
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Ms. Hui Wang (Age 54)
    CEO, Controller & Director
    Comp: $34.6k
  • Mr. Chi Ming Yu (Age 50)
    President, Treasurer, Compliance Officer & Director
  • Mr. Kai Gui (Age 54)
    Secretary, CFO, COO & Director
  • Prof. Puyi Sheng M.D. (Age 56)
    Ph.D., Chief Medical Officer
  • Prof. Shangli Liu M.D.
    Ph.D., Chairman of Scientific Board & Chief Medical Advisor of Greater China
  • Dr. John Thomas Lynch Jr.
    Chief Officer of Dental Technologies

ABMT Stock Analysis - Frequently Asked Questions

How have ABMT shares performed in 2024?

Advanced BioMedical Technologies' stock was trading at $0.0395 on January 1st, 2024. Since then, ABMT stock has decreased by 98.5% and is now trading at $0.0006.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Advanced BioMedical Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Advanced BioMedical Technologies investors own include Achieve Life Sciences (ACHV), Achillion Pharmaceuticals (ACHN), ACADIA Pharmaceuticals (ACAD), Arbutus Biopharma (ABUS), Abacus Property Group (ABP), Abiomed (ABMD), ARCA biopharma (ABIO), Abeona Therapeutics (ABEO) and Abcam (ABCZY).

How do I buy shares of Advanced BioMedical Technologies?

Shares of ABMT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ABMT) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners